Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) Patients

The role of the coagulation parameters in predicting the severity of COVID-19 disease will be assessed

Completed

Looking for future studies?

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag University, Sohag, Egypt

About this study

In COVID-19 patients the coagulation parameters Prothrombin concentration (PC), Activated Partial Thromboplastin Time (aPTT), D Dimer, Antithrombin III (ATIII) and Fibrinogen are measured and correlation with disease severity is to be investigated

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

● Confirmed cases with COVID 19

Exclusion criteria

● Known history of blood coagulopathy disorder

Treatment and study plan

Blood coagulation profile

Diagnostic Test

Venous blood sample for measurement of blood coagulation profile

Primary outcomes

correlation of disease severity with results of laboratory test

Time frame: Baseline results of coagulation profile and baseline disease severity assessment

The results of blood coagulation profile will be correlated with degree of severity of illness

Secondary outcomes

Agreement of abnormalities in coagulation profile with measured inflammatory markers

Time frame: baseline measurement of inflammatory markers

The inflammatory markers will be measured and correlation with abnormalities in coagulation profile will be assessed

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Blood Coagulation Abnormalities in COVID-19 Patients and Correlation With Severity

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Jul 29, 2021
Registry last updated: Jul 29, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed